REVVITY, INC Repayments of Senior Debt
REVVITY, INC (RVTY) reported Repayments of Senior Debt of $0 for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2026-02-24
- REVVITY, INC repayments of senior debt for the quarter ending 2025-12-28 was $0.00.
- REVVITY, INC repayments of senior debt for the quarter ending 2024-12-29 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC repayments of senior debt for the quarter ending 2024-09-29 was $711.48M, a 52.31% increase year-over-year.
- REVVITY, INC repayments of senior debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC repayments of senior debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- REVVITY, INC repayments of senior debt for fiscal 2024 was $711.48M, a 35.83% increase from fiscal 2023.
- REVVITY, INC repayments of senior debt for fiscal 2023 was $523.81M, a 805.05% increase from fiscal 2023.
- REVVITY, INC repayments of senior debt for fiscal 2023 was $57.88M, a 82.96% decline from fiscal 2022.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2025-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | ||
| 2025-09-28 | $0.00 10-Q · filed 2025-11-04 | |||
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $711.48M derived: sum of 2 quarters · filed 2026-02-24 | $711.48M derived: sum of 3 quarters · filed 2026-02-24 | $711.48M 10-K · filed 2026-02-24 |
| 2024-09-29 | $711.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $711.48M derived: sum of 2 quarters · filed 2025-11-04 | $711.48M 10-Q · filed 2025-11-04 | $717.31M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $5.83M derived: sum of 3 quarters · filed 2026-02-24 | $472.97M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $5.83M derived: sum of 2 quarters · filed 2026-02-24 | $472.97M derived: sum of 3 quarters · filed 2026-02-24 | $474.20M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $472.97M derived: sum of 2 quarters · filed 2026-02-24 | $474.20M derived: sum of 3 quarters · filed 2026-02-24 | $523.81M 10-K · filed 2026-02-24 |
| 2023-10-01 | $467.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $468.37M derived: sum of 2 quarters · filed 2024-11-06 | $517.97M 10-Q · filed 2024-11-06 | $568.38M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-07-02 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $50.84M 10-Q · filed 2024-08-06 | $101.24M derived: sum of 3 quarters · filed 2025-02-25 | $108.71M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-04-02 | $49.60M 10-Q · filed 2024-05-07 | $100.01M derived: sum of 2 quarters · filed 2025-02-25 | $107.48M derived: sum of 3 quarters · filed 2025-02-25 | $107.48M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-01-01 | $50.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $57.88M derived: sum of 2 quarters · filed 2025-02-25 | $57.88M derived: sum of 3 quarters · filed 2025-02-25 | $57.88M 10-K · filed 2025-02-25 |
| 2022-10-02 | $7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $7.47M derived: sum of 2 quarters · filed 2023-11-07 | $7.47M 10-Q · filed 2023-11-07 | $7.47M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-03 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | |
| 2022-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $339.61M 10-K · filed 2024-02-27 | |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $339.61M 10-Q · filed 2022-11-14 | ||
| 2021-07-04 | $339.61M 10-Q · filed 2022-08-09 | |||
| 2021-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2020-10-04 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-07-05 | $0.00 10-Q · filed 2021-08-10 | |||
| 2019-12-29 | $530.28M 10-K · filed 2022-03-03 | |||
| 2018-12-30 | $0.00 10-K · filed 2021-03-02 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |